"Prof. Christopher Huber". Biontech Biography. Biontech. Retrieved 5 August 2021. "SEC Filing | BioNTech". investors.biontech.de. p. 130. Retrieved 28 December...

The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...

at BioNTech's laboratories in Mainz, Germany, just days after the SARS-Cov-2 genetic sequence was first made public. In September 2020, BioNTech received...

Pfizer–BioNTech's BNT162b2 COVID-19 vaccine for widespread use. On 11 December, the FDA gave emergency use authorization for the Pfizer–BioNTech COVID-19...

delivery schedule for Pfizer-BioNTech’s COVID-19 vaccine." By the end of September, Canada will receive the 40 million Pfizer-BioNTech doses. Major General Fortin...

Bank to address the health and economic impact of COVID-19. Meanwhile, BioNTech and the European Union are collaborating to assess mRNA vaccine production...

approved the Pfizer-BioNTech vaccine for section 21 Emergency Use Authorisation. A trial ending in March 2021 of the Pfizer-BioNTech's COVID-19 vaccine appeared...

regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin...

company BioNTech, which in 2020 developed the first messenger RNA-based vaccine approved for use against COVID-19. Türeci has served as BioNTech's chief...

On 25 January 2021, the TGA provisionally approved the two-dose Pfizer–BioNTech COVID-19 vaccine, named COMIRNATY, for use within Australia. The provisional...